OTC · Healthcare

LFTD PARTNERS INC. (LIFD)

As-reported financials and recent SEC filings for LFTD PARTNERS INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$36.9M

Net income

$-24.9M

Net margin

-67.3%

Diluted EPS

$-1.68

ROE

-196.8%

P/E (TTM)

—

Market cap

—

Debt / equity

—

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$36.9M	$37.3M	$51.6M	$57.4M	$31.7M
Gross profit	$12.6M	$12.8M	$19.7M	$21.0M	$15.9M
Operating income	$913,208	$-773,464	$2.4M	$9.8M	$7.8M
Net income	$-24.9M	$-1.9M	$2.2M	$7.2M	$5.8M
Diluted EPS	$-1.68	$-0.13	$0.13	$0.45	$0.43

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

8-K2026-06-17

10-Q2026-05-15

10-K2026-04-01

NT 10-K2026-04-01

10-Q2025-11-14

10-Q2025-08-14

10-Q2025-05-15

8-K2025-04-16

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on LIFD

Search LFTD PARTNERS INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.